Biogen shutters a biotech shop in the UK as it continues to prune R&D
A little over two years ago, Biogen stepped in to buy Convergence Pharmaceuticals in the UK for $200 million in cash and up to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
